l General Information |
Product Name | PTC-028 |
General description | PTC-028 is an orally bioavailable compound that decreases BMI-1 levels by posttranslational modification. |
Synonym | EX-A1647; 6-(5,6-difluoro-2-methylbenzimidazol-1-yl)-N-[4-(trifluoromethyl)phenyl]pyrazin-2-amine |
Purity | ≥98.5%(HPLC) | CAS Number | 1782970-28-8 |
Formula | C19H12F5N5 | Molecular Weight | 405.32 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Solid |
Solubility(25°C) | DMSO | ≥50mg/mL |
Ethanol | ≥5mg/mL |
Water | Very slightly soluble |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
